Manufacturing depression (62 page)

Crooked Lake Review.
Available online at
www.crookedlakereview.com
.

Curtis, D. R., and R. M. Eccles. “The Excitation of Renshaw Cells by Pharmacological Agents Applied Electrophoretically.”
Journal of Physiology
141 (1958): 434–45.

Dahlstrom, A., and A. Carlsson. “Making Visible the Invisible: Recollections of the First Experiences with the Histochemical Fluorescence Method for Visualization of Tissue Monoamines.” In
Discoveries in Pharmacology, vol. 3: Pharmacological Methods, Receptors, and Chemotherapy,
edited by M. J. Parnham and J. Bruinvels. Amsterdam: Elsevier, 1983, pp. 97–125.

Davies, D. L., and M. Shepherd. “Reserpine in the Treatment of Anxious Patients.”
Lancet
2 (1955): 117–20.

Davies, J. D.
Phrenology: Fad and Science.
Hamden, CT: Archon Books, 1971 (originally published 1955).

Daw, J. “Is PMDD Real?”
APA Monitor
33, no. 9 (October 2002). Available online at
http://www.apa.org/monitor/oct02/pmdd.html
.

Depression Guideline Panel, Agency for Health Care Policy and Research, US Department of Health and Human Services.
Treatment of Major Depression: Clinical Practice Guideline Number 5.
Rockville, MD: Public Health Service, 1993.

Depression Is Real Coalition. “Link to Us.” DepressionIsReal.org website. Available at
http://www.depressionisreal.org/depression-link.html
.

———. “‘Right and Wrong’ Radio Advertisement Featuring Dr. Greengard.” DepressionIsReal.org website, The Depression Is Real Campaign. Available online at
http://www.depressionisreal.org/depression-dr-greengard.html
.

———. “What Is.” DepressionIsReal.org website. Available at
http://depressionisreal.org/depression-about-coalition.html
.

DeRubeis, R. J., and A. T. Beck. “Cognitive Therapy.” In
Handbook of Cognitive-Behavioral Therapies
, edited by K. S. Dobson. New York: Guilford Press, 1988.

Dobson, K. S. “A Meta-analysis of the Efficacy of Cognitive Therapy for Depression.”
Journal of Consulting and Clinical Psychology
57 (1989): 414–19.

Dreyfus, G. L.
Die Melancholie: Ein Zustandsbild des Manisch-Depressiven Irreseins.
Jena: Gustave Fischer, 1907.

Dufresne, T.
Against Freud: Critics Talk Back.
Stanford, CA: Stanford University Press, 2007.

El-Haj, J.
The Lobotomist: A Maverick Medical Genius and His Tragic Quest to Rid the World of Mental Illness.
Hoboken, NJ: John Wiley & Sons, 2005.

Eli Lilly and Company. “Prozac Makes History.” Prozac, Fluoxetine Hydrochloride website, Lilly USA LLC, 2009. Available online at
http://www.prozac.com/disease_information/treatment_depression.jsp?reqNavId=1.1.4
.

Elkin, S.
The MacGuffin.
Champaign, IL: Dalkey Archive Press, 1999.

Elliott, S. “A New Campaign by Leo Burnett Will Try to Promote Prozac Directly to Consumers.”
New York Times
, July 1, 1997.

Erowid. Website. Available online at
www.erowid.org
.

Fava, M. “Prospective Studies of Adverse Events Related to Antidepressant Discontinuation.”
Journal of Clinical Psychiatry
, 67, suppl. 4 (2007): 14–21.

Feighner, J. P., R. Munoz, G. Winokur, R. A. Woodruff, Jr., S. B. Guze, and E. Robins. “Diagnostic Criteria for Use in Psychiatric Research.”
Archives of General Psychiatry
26 (1972): 57–63.

Finger, S.
Minds behind the Brain: A History of the Pioneers and Their Discoveries.
Oxford: Oxford University Press, 2000.

Fink, M. “The Medical Evidence-Based Model for Psychiatric Syndromes: Return to a Classical Paradigm.”
Acta Psychiatrica Scandinavica
116 (2008): 81–84.

———. “Meduna and the Origins of Convulsive Therapy.”
American Journal of Psychiatry
141 (September 1984): 1034–41.

Fitzgerald, P. J. “A Neurotransmitter System Theory of Sexual Orientation.”
Journal of Sexual Behavior
5, no. 3 (2008): 746–48.

Flynn, J. “Prozac Is Making Lilly a Little Edgy.”
BusinessWeek,
June 22, 1992.

Foa, E. B., B. O. Rothbaum, D. S. Riggs, and T. B. Murdock. “Treatment of Post-traumatic Stress Disorder in Rape Victims: A Comparison Between Cognitive-Behavioral Procedures and Counseling.”
Journal of Consulting and Clinical Psychology
59 (1991): 715–23.

Foucault, M.
Madness and Civilization.
New York: Random House, 1965.

Fowler, O. S., and L. N. Fowler.
The Self Instructor in Phrenology and Physiology: With Over One Hundred New Illustrations, Including a Chart for the Use of Practical Phrenologists.
New York: Fowler & Wells, 1859.

Frederick the Great. “Eulogy on La Mettrie.” In J. O. de La Mettrie,
Man a Machine (Homme-machine)
, edited by Gertrude Carman Bussey, 3–9. La Salle, IL: Open Court, 1912.

Freeman, Lucy. “Advantages Noted in Shock Therapy.”
New York Times
, December 18, 1949.

Freud, Sigmund.
Beyond the Pleasure Principle.
New York: W. W. Norton, 1961.

———.
Civilization and Its Discontents.
London: Penguin Books, 2002.

———. “Mourning and Melancholia.” In
On Murder, Mourning, and Melancholia
, 201–19. London: Penguin Books, 2005.

———.
The Question of Lay Analysis: Conversations with an Impartial Person.
New York: W. W. Norton, 1989.

———. “Transience.” In
On Murder, Mourning, and Melancholia
, 195–200. London: Penguin Books, 2005.

Frostig, J. P. “Clinical Observations in Insulin Treatment of Schizophrenia: Preliminary Report.”
American Journal of Psychiatry
96 (1940): 1167–90.

Gaddum, J. H. “Antagonism between Lysergic Acid Diethylamide and 5-hydroxytryptamine.”
Journal of Physiology
121, suppl., no. 1 (1953): 15P.

———. “Push-Pull Cannulae,”
Journal of Physiology
155, suppl. no. 1 (1961): 1P–2P.

Gaddum, J. H., and K. A. Hameed. “Drugs Which Antagonize 5-hydroxytryptamine.”
British Journal of Pharmacology
9 (1954): 240–48.

Gaddum, J. H., and M. Vogt. “Some Central Actions of 5-hydroxytryptamine and Various Antagonists.”
British Journal of Pharmacology
11 (1956): 175–79.

Garfield, S.
Mauve: How One Man Invented a Color That Changed the World.
New York: W. W. Norton, 2000.

Gay, P.
Freud: A Life for Our Time.
New York: W. W. Norton, 1988.

Geddes, J. R., N. Freemantle, J. Mason, M. P. Eccles, and J. Boynton. SSRIs versus other antidepressants for depressive disorder.
Cochrane Database of Systematic Reviews
, 2 (2000): CD001851. Available online at
http://www.cochrane.org/reviews/en/info_427099072210033858.html
.

Gergen, K. J. “The Social Constructionist Movement in Modern Psychology.”
American Psychologist
40 (1985): 266–75.

Gilbody, S., P. Wilson, and I. Watts. “Direct-to-Consumer Advertising of Psychotropics: An Emerging and Evolving Form of Pharmaceutical Company Influence.”
British Journal of Psychiatry
185 (2004): 1–2.

Gilman, C. P. “The Yellow Wallpaper.” In
The Yellow Wallpaper and Other Writings
, 1–18. New York: Bantam, 2006 (originally published 1892).

GlaxoSmithKline. “New Survey Reveals Common yet Underrecognized Disorder—Restless Legs Syndrome—Is Keeping America Awake at Night.” Press release, June 10, 2003. Available online at
www.gsk.com/press_archive/press2003/press_06102003.htm
.

———. “Prescribing Information: Paxil (Paroxetine Hydrochloride).” Available online at
http://us.gsk.com/products/assets/us_paxil.pdf
.

Glenmullen, J.
Prozac Backlash: Overcoming the Dangers of Prozac, Zoloft, Paxil, and other Antidepressants with Safe, Effective Alternatives
. New York: Simon & Schuster, 2000.

Goenka, A. H. “Rustom Jal Vakil and the Saga of
Rauwolfia serpentina
.”
Journal of Medical Biography
15 (2007): 195–200.

Goffman, E.
Stigma: Notes on the Management of Spoiled Identity.
New York: Touchstone, 1986.

Gold, H., N. T. Kwit, and H. Otto. “The Xanthines (Theobromine and Aminophylline) in the Treatment of Cardiac Pain.”
Journal of the American Medical Association
108 (1937): 2173–79.

Goldberg, D. “A Dimensional Model for Common Mental Disorders.”
British Journal of Psychiatry
1996, suppl. 30: 44–49.

Green, A. R. “Gaddum and LSD: the Birth and Growth of Experimental and Clinical Neuropharmacology Research on 5-HT in the UK.”
British Journal of Pharmacology
154, no. 8 (2008): 1–17.

Greenberg, G. “Is It Prozac? Or Placebo?”
Mother Jones
, Nov.–Dec. 2003, pp. 76–80.

Grob, G. “Origins of DSM-I: A Study in Appearance and Reality.”
American Journal of Psychiatry
128 (1991): 421–31.

Grof, S. “Stanislav Grof Interviews Dr. Albert Hofmann.”
MAPS
(Multidisciplinary Association for Psychedelic Studies) 11 (2002): 22–35. Available online at
http://www.maps.org/news-letters/v11n2/11222gro.html
.

Hamilton, M. “A Rating Scale for Depression.”
Journal of Neurology, Neurosurgery, and Psychiatry
23 (1960): 56–62.

Harrison, E. “TB Drug Is Tried in Mental Cases.”
New York Times
, April 7, 1957.

Hazel, J.
Who’s Who in the Greek World.
New York: Routledge, 2001.

Healy, D.
The Antidepressant Era.
Cambridge, MA: Harvard University Press, 1997.

———.
The Creation of Psychopharmacology.
Cambridge, MA: Harvard University Press, 2002.

———.
Mania: A Short History of Bipolar Disorder.
Baltimore, MD: Johns Hopkins University Press, 2008.

Hippocrates.
Hippocratic Writings,
translated by Francis Adams. Chicago: Encyclopaedia Britannica, 1952.

———.
On the Nature of Man.
Vol. 4 in
Hippocrates
, translated by W. H. S. Jones. Cambridge, MA: Loeb Classical Library, 1931.

Hirschfeld, R. M., M. Keller, S. Panico, B. Arons, D. Barlow, F. Davidoff, J. Endicott, et al. “The National Depressive and Manic-Depressive Association Consensus Statement on the Undertreatment of Depression.”
JAMA
277, no. 4 (1997): 333–40.

Hoch, A., and J. T. MacCurdy. “The Prognosis of Involution Melancholia.”
Archives of Neurology and Psychiatry
7 (January 1922): 1–18.

Hofmann, Albert.
LSD: My Problem Child.
Sarasota, FL: Multidisciplinary Association for Psychedelic Studies (MAPS), 2005 (originally published 1979).

Hollister, L. E. “Mental Disorders: Antianxiety and Antidepressant Drugs.”
New England Journal of Medicine
286 (1972): 1195–98.

Hollon, S. D., M. E. Thase, and J. C. Markowitz. “Treatment and Prevention of Depression.”
Psychological Science in the Public Interest
3, no. 2 (2002): 39–77.